Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP847032.RAbijB_JDezLYWhS3n6-z5l4PSXiOxVYgfXRDzGRzXEcw130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847032.RAbijB_JDezLYWhS3n6-z5l4PSXiOxVYgfXRDzGRzXEcw130_provenance.
• assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP519511.RAvmWtTDLNX4ZbKfnrCMsV_vohiPrcWBmJP8qRNVTjLNk130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519511.RAvmWtTDLNX4ZbKfnrCMsV_vohiPrcWBmJP8qRNVTjLNk130_provenance.
• NP591999.RA85hVnXkCmCLQJDx7P9L10o9eCYR_QGuMtIu0aMb8aAE130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591999.RA85hVnXkCmCLQJDx7P9L10o9eCYR_QGuMtIu0aMb8aAE130_provenance.
• NP577588.RAh2Vr0CXxZiUdTzwW1sw8pdwbmHUJOyPv4mfAnf5ataM130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577588.RAh2Vr0CXxZiUdTzwW1sw8pdwbmHUJOyPv4mfAnf5ataM130_provenance.
• NP776956.RAbwV3Fs9GMOxxn3WbUDJQMnaVro9ZE-bxjqIlqduePbU130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776956.RAbwV3Fs9GMOxxn3WbUDJQMnaVro9ZE-bxjqIlqduePbU130_provenance.
• NP453394.RAzNhi18HoZbf5AIxuRNlo_Sq6bD-b8fek3fsG2vBnknA130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453394.RAzNhi18HoZbf5AIxuRNlo_Sq6bD-b8fek3fsG2vBnknA130_provenance.
• NP236249.RAyxnjhMYRw7_1fCDWgnpadKkaz2Qm2Vv_iDTzO3RML-4130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236249.RAyxnjhMYRw7_1fCDWgnpadKkaz2Qm2Vv_iDTzO3RML-4130_provenance.
• NP67863.RAZ63IHge1-N4pt5ro9a9C1RVOE30Pbwlk1EWnU6oybJo130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67863.RAZ63IHge1-N4pt5ro9a9C1RVOE30Pbwlk1EWnU6oybJo130_provenance.
• NP217374.RAXoG-9kGkgaZgHGRvwBCjPiOV-aJTVj9GP2WWbRY37c0130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217374.RAXoG-9kGkgaZgHGRvwBCjPiOV-aJTVj9GP2WWbRY37c0130_provenance.
• NP840265.RA8_y3tui057MbH8qZhA2oLHaEf2C-XMHg2m0fKZkiuAc130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840265.RA8_y3tui057MbH8qZhA2oLHaEf2C-XMHg2m0fKZkiuAc130_provenance.
• NP698110.RAdR0j7zJIZe9kT5smuPTmhSozuDJdiw0IacQJrtrSgYQ130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698110.RAdR0j7zJIZe9kT5smuPTmhSozuDJdiw0IacQJrtrSgYQ130_provenance.
• NP857760.RAavytX7btOEPP1uX_LRZ5MWTVnc3CBi4zI1UllE_loYc130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857760.RAavytX7btOEPP1uX_LRZ5MWTVnc3CBi4zI1UllE_loYc130_provenance.
• NP93992.RAc11Buel-6lqRgBwHFzcnqRlMQf4fBJKK5fRPk7ZdwvE130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP93992.RAc11Buel-6lqRgBwHFzcnqRlMQf4fBJKK5fRPk7ZdwvE130_provenance.
• NP857836.RAvKyL2twOIXMsXZ6YWI3T5IjgRBvYT67CbjvUna8z5Dk130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857836.RAvKyL2twOIXMsXZ6YWI3T5IjgRBvYT67CbjvUna8z5Dk130_provenance.
• NP503069.RAeDKUa15X8lg9zGzb5ExFEvGDImGRgQ1qQgpb7FCYW3Q130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503069.RAeDKUa15X8lg9zGzb5ExFEvGDImGRgQ1qQgpb7FCYW3Q130_provenance.
• NP974312.RAvlgDmg_lwwHdc_K6zprxucFUnWyFsB1lqOHshtru6io130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974312.RAvlgDmg_lwwHdc_K6zprxucFUnWyFsB1lqOHshtru6io130_provenance.
• NP974381.RAgkN_3TurEUEQI59L02sQRbXjaZILXIbnPw6LWrT4hFo130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974381.RAgkN_3TurEUEQI59L02sQRbXjaZILXIbnPw6LWrT4hFo130_provenance.
• NP697908.RAvvY-YE8gO4Q3zS-TyFZKv1k1v_OgE_pLdcO9Wlm_rrw130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697908.RAvvY-YE8gO4Q3zS-TyFZKv1k1v_OgE_pLdcO9Wlm_rrw130_provenance.
• NP503055.RAgYda3uGuuLZS0W41c122uTeaDIFec2tDXqrB3QJfnGg130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503055.RAgYda3uGuuLZS0W41c122uTeaDIFec2tDXqrB3QJfnGg130_provenance.
• NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_provenance.
• NP503063.RAl9xtyaaVPn4wIrUB1iudf7jQbpqOtJFDAQ-3rB_OvMo130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503063.RAl9xtyaaVPn4wIrUB1iudf7jQbpqOtJFDAQ-3rB_OvMo130_provenance.
• NP372457.RA0eGGHisOThmVRistu7oUvZh7PyKCN-_R3q2daOPlEdA130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372457.RA0eGGHisOThmVRistu7oUvZh7PyKCN-_R3q2daOPlEdA130_provenance.
• NP217293.RANEHtBoggLxpNu8MOYQYvt_ymMortirOZjk6feVwQnKA130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217293.RANEHtBoggLxpNu8MOYQYvt_ymMortirOZjk6feVwQnKA130_provenance.
• NP372548.RAJ9f0r053eWOX2cmKSP9AaoxGYKn-S9swqse93RAgVJ0130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372548.RAJ9f0r053eWOX2cmKSP9AaoxGYKn-S9swqse93RAgVJ0130_provenance.
• NP503070.RAOSuyAsxbLQkOZcA9rFFIcpb4wm4u6I3mrxsH78bmeQg130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503070.RAOSuyAsxbLQkOZcA9rFFIcpb4wm4u6I3mrxsH78bmeQg130_provenance.
• NP503057.RA_ieGf5FBw86Y6VqGSh7WBE_MRA_G0AsAc-rndlbNTME130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503057.RA_ieGf5FBw86Y6VqGSh7WBE_MRA_G0AsAc-rndlbNTME130_provenance.
• NP503058.RA8vOZT1Mg9o1b7Lu2K9ToUGceowFkO28W56vEGdtX4XM130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503058.RA8vOZT1Mg9o1b7Lu2K9ToUGceowFkO28W56vEGdtX4XM130_provenance.
• NP503061.RA9L3wjbiajQUjXu3koGtGy0KdfaDe5A1xh0OZ88DlZcA130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503061.RA9L3wjbiajQUjXu3koGtGy0KdfaDe5A1xh0OZ88DlZcA130_provenance.
• NP503066.RA_MVh6FTEv8PbydYteXLnnEbgtmc4RnUDBLPK_Wot_pc130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503066.RA_MVh6FTEv8PbydYteXLnnEbgtmc4RnUDBLPK_Wot_pc130_provenance.
• NP503071.RA83Q2n_KqajwOXOCW1NZykMp3-zQZ1m_EcfUsGWK41yw130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503071.RA83Q2n_KqajwOXOCW1NZykMp3-zQZ1m_EcfUsGWK41yw130_provenance.